Press release
Non-Muscle Invasive Bladder Cancer Market Size is Anticipated to Grow at a CAGR of 21.4% by 2034 | TMR Study
Non-muscle Invasive Bladder Cancer Market
Non-Muscle Invasive Bladder Cancer Market (비근육 침윤성 방광암 시장) is expected to grow at a CAGR of 21.4% from 2024 to 2034 and reach US$ 21.1 Bn by the end of 2034
Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86334
Overview of Non-Muscle Invasive Bladder Cancer Market
The global NMIBC market is experiencing substantial growth due to the rising incidence of bladder cancer, technological advancements in diagnostics and treatments, and increasing awareness about early detection and management. The market is segmented by treatment type (surgery, intravesical therapy, chemotherapy, immunotherapy, others), diagnostic method (cystoscopy, urine cytology, biomarkers, imaging), end-users (hospitals, cancer centers, research institutes), and geographical regions.
Top Companies:
TARIS Biomedical LLC
Merck & Co., Inc.
Herantis Pharma Oyj
Viventia Bio Inc.
Telormedix SA
Ferring B.V.
Altor BioScience Corporation
Novartis AG
Pfizer Inc.
GSK plc
Sanofi S.A.
Eli Lilly and Company
AstraZeneca
Recent Developments in NMIBC Market
Recent advancements and trends in the NMIBC market include:
Enhanced Diagnostic Techniques: Development of advanced diagnostic tools such as narrow band imaging (NBI), blue light cystoscopy, and urinary biomarkers for more accurate detection and monitoring of NMIBC.
Intravesical Therapies: Progress in intravesical therapies, including Bacillus Calmette-Guérin (BCG) and chemotherapeutic agents like mitomycin C and gemcitabine, to prevent recurrence and progression.
Novel Immunotherapies: Introduction of novel immunotherapies, including immune checkpoint inhibitors and vaccine-based therapies, to enhance the immune response against bladder cancer cells.
Targeted Therapies: Emerging targeted therapies that focus on specific molecular pathways involved in NMIBC, offering personalized treatment options.
Minimally Invasive Techniques: Advancements in minimally invasive surgical techniques such as transurethral resection of bladder tumor (TURBT) to effectively remove tumors with fewer complications.
Drivers of Market Growth
Several factors contribute to the growth of the NMIBC market:
Rising Incidence of Bladder Cancer: Increasing global incidence of bladder cancer due to factors such as aging populations, smoking, and exposure to carcinogens.
Technological Advancements: Continuous advancements in diagnostic and therapeutic technologies enhancing the effectiveness of NMIBC management.
Early Detection and Screening Programs: Implementation of early detection and screening programs leading to timely diagnosis and treatment of NMIBC.
Increasing Healthcare Expenditure: Rising healthcare expenditure and government funding for cancer research and treatment.
Patient Awareness and Education: Growing awareness and education among patients about the importance of early detection and treatment adherence.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86334
Conclusion
The NMIBC market is poised for significant growth, driven by rising bladder cancer prevalence, technological advancements in diagnostics and treatments, and increasing awareness about early detection and management. Innovations in diagnostic techniques, intravesical therapies, immunotherapies, targeted therapies, and minimally invasive techniques are enhancing the effectiveness and accessibility of NMIBC treatments.
Market Segmentation:
Treatment Type
Immunotherapy
Chemotherapy
Targeted Therapy
Cancer Type
Low Grade Bladder Cancer
High Grade Bladder Cancer
End-user
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86334<ype=S
More Trending Report by Transparency Market Research:
OPGW Cable Market (Marché des câbles OPGW): https://www.globenewswire.com/news-release/2024/02/28/2837197/32656/en/OPGW-Cable-Market-Expected-to-Reach-USD-876-8-million-by-2031-Growing-at-a-CAGR-of-4-8-Transparency-Market-Research-Inc.html
Pharmaceutical Chemicals Market (医薬品化学品市場): https://www.globenewswire.com/en/news-release/2024/01/15/2808957/32656/en/Pharmaceutical-Chemicals-Market-Size-to-be-Worth-USD-339-3-billion-by-2031-with-a-Projected-CAGR-of-5-8-Says-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Muscle Invasive Bladder Cancer Market Size is Anticipated to Grow at a CAGR of 21.4% by 2034 | TMR Study here
News-ID: 3584116 • Views: …
More Releases from Transparency Market Research
Automotive Tinting Film Market to be Worth USD 7.5 Bn by 2035 - By Film Type / B …
The global automotive tinting film market was valued at US$ 4.8 billion in 2024 and is projected to reach US$ 7.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2035. This steady growth reflects the increasing adoption of tinting films across passenger and commercial vehicles, supported by growing consumer awareness regarding comfort, safety, and vehicle preservation.
Preview crucial insights and findings from our…
Global Meat Substitutes Market Poised for Robust Growth, set to Reach 20,100.0 M …
The global meat substitutes market is undergoing a rapid transformation, emerging as one of the most dynamic and fast-evolving segments within the global food industry. According to the latest industry analysis, the market was valued at US$ 7,532.3 Mn in 2024 and is projected to reach US$ 20,100.0 Mn by 2035, expanding at a healthy compound annual growth rate (CAGR) of 9.4% from 2025 to 2035. This strong growth trajectory…
Wrist Dive Computer Market Outlook 2035: Global Market to Grow from US$ 258.6 Mn …
The global wrist dive computer market is steadily expanding as recreational and professional diving activities gain popularity worldwide. Valued at US$ 258.6 million in 2024, the market is projected to reach US$ 436.9 million by 2035, growing at a compound annual growth rate (CAGR) of 4.9% from 2025 to 2035. This growth reflects rising participation in scuba and freediving, increasing safety awareness among divers, and continuous innovation in wearable dive…
NOR Flash Market Outlook 2035: Automotive Electronics-Driven Growth to US$ 11.5 …
The global NOR Flash Market(https://www.transparencymarketresearch.com/nor-flash-market.html) was valued at US$ 2.6 Bn in 2024 and is projected to reach US$ 11.5 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2035. This sustained growth trajectory reflects the rising importance of reliable, fast-boot, and high-endurance non-volatile memory in embedded systems. Unlike data-centric storage technologies, NOR Flash remains indispensable for code storage, firmware execution, and mission-critical…
More Releases for NMIBC
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Market Growth 2034
Market Overview
The BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Market is gaining strong traction as the demand for effective second-line therapies continues to rise. Patients who do not respond to Bacillus Calmette-Guérin (BCG) therapy face a high risk of disease progression, creating significant need for innovative treatment options.
The market is driven by immunotherapies, targeted therapies, combination drugs, gene therapies, and next-generation intravesical treatments. Rising disease prevalence, increasing awareness of early…
NMIBC Pipeline Drugs Insights Report 2025: Emerging Therapeutics and Market Oppo …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further…
Non-Muscle Invasive Bladder Cancer (NMIBC) Patient Pool Analysis Market Massive …
Introduction
Bladder cancer is one of the most common cancers worldwide, and non-muscle invasive bladder cancer (NMIBC) accounts for nearly 70-75% of all newly diagnosed cases. NMIBC is characterized by tumors confined to the mucosa or submucosa, making it less aggressive than muscle-invasive bladder cancer (MIBC). However, recurrence rates remain high, and progression to advanced stages is a significant concern.
The NMIBC patient pool is expanding globally due to an aging population,…
BCG-unresponsive NMIBC market is projected to reach $4.1 billion by 2034
Bladder cancer is among the most common urologic malignancies worldwide, with non-muscle invasive bladder cancer (NMIBC) representing approximately 70-75% of all new cases. Standard first-line therapy involves transurethral resection followed by intravesical instillation of Bacillus Calmette-Guérin (BCG). While effective in many cases, a significant subset of patients becomes BCG-unresponsive, meaning their disease progresses or recurs despite adequate treatment. This presents a serious clinical challenge, as these patients are at high…
NMIBC Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Poten …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further…
Non Muscle Invasive and Metastatic Bladder Cancer (NMIBC) Market 2017 Industry D …
Global Non Muscle Invasive and Metastatic Bladder Cancer (NMIBC) Market: Snapshot
Non-muscle invasive and metastatic bladder cancer causes malignancy of the urinary tract. The most common symptoms of non-muscle invasive and metastatic bladder cancer include blood or blood clots in the urine. This is also known as hematuria, which affects almost 8 to 9 out of 10 patients and is often regarded as the most common symptom. Other symptoms include painful…
